Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

Novel Microscope Enables Direct Mass Spectrometry Analysis

By BiotechDaily International staff writers
Posted on 07 May 2013
Print article
Image: The iMScope –  Shimadzu’s novel imaging mass microscope (Photo courtesy of Shimadzu).
Image: The iMScope – Shimadzu’s novel imaging mass microscope (Photo courtesy of Shimadzu).
A unique imaging mass microscope has been developed as a new research tool that offers mass spectrometric analysis capability in a single instrument and resolution enabling the visualization of the sub-cellular distribution of molecules.

The positional information of molecules is lost in traditional mass spectrometric analysis. Shimadzu Corporation (Kyoto, Japan) introduces the “iMScope” imaging mass microscope, a new hybrid type of microscope that combines both an optical microscope and an atmospheric pressure ionization mass spectrometer. The optical microscope allows the observation of high-resolution morphological images, and the hybrid ion trap time of flight mass spectrometer allows both identification and visualization of the distribution of specific molecules in the sectioned sample of interest. In addition, the relative abundance of specific molecules (such as drugs and their metabolites) localized in different tissues can be resolved and compared. The dedicated software for the iMScope, “Imaging MS Solution,” can set all operational parameters for viewing optical microscope images, and many sets of operation parameters are available as default method files; hence, users can perform the imaging mass spectrometry without troublesome additional settings.

Proprietary ultrafocusing laser optics and the highly reproducible, high precision 3D automated sample transfer stage result in a superior spatial mass spectrometry resolution of 5 µm—finest spatial resolution in imaging mass spectrometry, using matrix assisted laser desorption ionization (MALDI-TOF) mass spectrometer, commercially available. The iMScope is capable of analyzing living cells or tissue samples by atmosphere MALDI. By superimposing the two images obtained based on these different principles, the team of scientists from Shimadzu, Hamamatsu University of Medicine, and Keio University have created this powerful new research tool.

The iMScope expands potential research opportunities to a diversity of fields, including direct analyses of biological samples as well as of manufactured devices. Potential biological applications include disease biomarker research and functional biology research, such as for development of early stage cancer indicators with biomarkers in cancer tissue; for analysis of micro tissue (smaller than 10 µm; e.g., pigment layer of the retina); as a new pharmacokinetics tool monitoring drug metabolism; and for advancing agricultural and horticultural products via locating the distribution of key compounds. The iMScope is also well suited for various industrial applications, particularly for defect analysis of electronic components and synthetic polymer materials.

In addition to enabling direct analysis of optical microscope samples, the use of atmosphere MALDI, compared to vacuum MALDI, enables analysis of volatile molecules and biological tissues closer living conditions, as well as shorter instrument start-up time. Additionally, the high speed Nd:YAG laser can ionize molecules at 1 kHz, and original ion optics can acquire the ions (which are ionized by several laser shots) and analyze those at once, as this novel technology provides about 100 times faster high-speed imaging mass spectrometry than conventional mass spectrometers. Hence, the ultra-fast performance of the iMScope also accelerates research progress.

The iMScope will be presented at both KSBMB 2013, Korean Society of Biochemistry and Molecular Biology (May 14-16, 2013) and ASMS 2013, American Society of Mass Spectrometry (June 9-13, 2013, in Minneapolis, MN, USA), in conjunction with the new iMLayer, matrix sample preparation device for tissue imaging.

Related Links:
Shimadzu
iMScope


Print article

Channels

Genomics/Proteomics

view channel
Image: Follicular helper T-cells (TFH cells, shown in blue) play a crucial role in the maturation of antibody-producing B-cells (shown in green). Activated B-cells give rise germinal centers (shown in red), where mature B-cells proliferate and produce highly specific antibodies against pathogens. Top left: normal germinal center in a mouse tonsil. All others: Germinal centers fail to form when the interaction between ICOS and TBK1 is interrupted (Photo courtesy of Dr. Kok-Fai Kong, La Jolla Institute for Allergy and Immunology).

Molecular Pathway Controlling High-affinity Antibody Production Identified

A molecular pathway has been identified that controls formation of follicular helper T-cells (TFH cells) germinal centers and production of high-affinity antibodies through interaction with the inducible... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.